CC BY-NC 4.0 · Arch Plast Surg 2015; 42(02): 214-217
DOI: 10.5999/aps.2015.42.2.214
Case Report

Treatment of Eyelid Ptosis due to Kearns-Sayre Syndrome Using Frontalis Suspension

Laurenz Weitgasser
Department of Plastic, Aesthetic, and Reconstructive Surgery, Krankenhaus Barmherzige Brueder Salzburg, Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria
,
Gottfried Wechselberger
Department of Plastic, Aesthetic, and Reconstructive Surgery, Krankenhaus Barmherzige Brueder Salzburg, Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria
,
Florian Ensat
Department of Plastic, Aesthetic, and Reconstructive Surgery, Krankenhaus Barmherzige Brueder Salzburg, Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria
,
Rene Kaplan
Department of Plastic, Aesthetic, and Reconstructive Surgery, Krankenhaus Barmherzige Brueder Salzburg, Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria
,
Michaela Hladik
Department of Plastic, Aesthetic, and Reconstructive Surgery, Krankenhaus Barmherzige Brueder Salzburg, Teaching Hospital of the Paracelsus Medical University, Salzburg, Austria
› Author Affiliations

Blepharoptosis is a common indication for surgery in plastic surgery units, yet its possible underlying pathology frequently remains unidentified. A 52-year-old man with a 20-year history of progressive bilateral ptosis (right>left) presented with recurrent ptosis of both eyes; he had undergone an operation on the levator aponeurosis 12 years prior. Due to the suspicion of an underlying disease, he was evaluated further. Chronic progressive external ophthalmoplegia in transition to the more severe syndromic variant Kearns-Sayre syndrome, a mitochondrial disorder causing myopathy, was diagnosed. The patient was treated with coenzyme Q10, and he underwent ptosis surgery on both eyes. This case illustrates a potentially multi-systemic disease that was diagnosed by a further evaluation of a common symptom, in this case worsening blepharoptosis. Awareness of myopathic symptoms is necessary to prevent overlooking serious yet improvable conditions.



Publication History

Received: 24 September 2014

Accepted: 23 December 2014

Article published online:
05 May 2022

© 2015. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • REFERENCES

  • 1 Kearns TP, Sayre GP. Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol 1958; 60: 280-289
  • 2 Park SB, Ma KT, Kook KH. et al. Kearns-Sayre syndrome: 3 case reports and review of clinical feature. Yonsei Med J 2004; 45: 727-735
  • 3 Papageorgiou G, Vlachos S, Tentis D. Blepharoptosis due to Kearns-Sayre syndrome. J Plast Reconstr Aesthet Surg 2008; 61: 573-574
  • 4 Kearns TP. External ophthalmoplegia, pigmentary degeneration of the retina, and cardiomyopathy: a newly recognized syndrome. Trans Am Ophthalmol Soc 1965; 63: 559-625
  • 5 Ogasahara S, Nishikawa Y, Yorifuji S. et al. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 1986; 36: 45-53
  • 6 Eshaghian J, Anderson RL, Weingeist TA. et al. Orbicularis oculi muscle in chronic progressive external ophthalmoplegia. Arch Ophthalmol 1980; 98: 1070-1073
  • 7 Salvi SM, Currie ZI. Frontalis suspension sling using palmaris longus tendon in chronic progressive external ophthalmoplegia. Ophthal Plast Reconstr Surg 2009; 25: 140-141
  • 8 Lane CM, Collin JR. Treatment of ptosis in chronic progressive external ophthalmoplegia. Br J Ophthalmol 1987; 71: 290-294